Search filters

List of works by Mark Yarchoan

A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer

scientific article published on 26 December 2019

Association between pretreatment lymphocyte count and response to PD1 inhibitors in head and neck squamous cell carcinomas

scientific article published on 31 August 2018

BRAF mutation and thyroid cancer recurrence.

scientific article published on 24 November 2014

Characterization of the Immune Microenvironment in Hepatocellular Carcinoma (HCC).

scientific article published on 19 September 2017

Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors

scientific article published on 13 March 2019

Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancer

scientific article published on 18 October 2018

Diagnostic intervals and pancreatic ductal adenocarcinoma (PDAC) resectability: a single-center retrospective analysis

scientific article published on 27 February 2018

Duplex ultrasound imaging to detect limb stenosis or kinking of endovascular device ⬇️

scientific article published on February 16, 2012

Histopathological and Immunophenotypic Features of Ipilimumab-Associated Colitis Compared to Ulcerative Colitis.

scientific article published on 21 February 2018

Immune-Related Adverse Events Requiring Hospitalization: Spectrum of Toxicity, Treatment, and Outcomes

scientific article published on 06 August 2019

Immuno-oncology Trial Endpoints: Capturing Clinically Meaningful Activity.

scientific article published in September 2017

Ipilimumab-Induced Enteritis without Colitis: A New Challenge

scientific article

MEK inhibition suppresses B regulatory cells and augments anti-tumor immunity

scientific article published on 31 October 2019

Mechanistically detailed systems biology modeling of the HGF/Met pathway in hepatocellular carcinoma

scientific article published on 16 August 2019

Multipanel mass cytometry reveals anti-PD-1 therapy-mediated B and T cell compartment remodeling in tumor-draining lymph nodes

scientific article published on 30 January 2020

Multiple Immune-Suppressive Mechanisms in Fibrolamellar Carcinoma

scientific article published on 22 March 2019

Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition.

scientific article

Olaparib in combination with irinotecan, cisplatin, and mitomycin C in patients with advanced pancreatic cancer.

scientific article published on 19 April 2017

Oligometastatic Adenocarcinoma of the Lung: A Therapeutic Opportunity for Long-Term Survival

scientific article published on 16 December 2015

PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers

scientific article published on 21 March 2019

Pan-Tumor Pathologic Scoring of Response to PD-(L)1 Blockade

scientific article published on 31 October 2019

Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival

scientific article published on 01 May 2019

Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma

scientific article published on 01 September 2019

Reply to C. Bal et al and M. Xing.

scientific article

Successful Treatment of Neoplastic Fever with Oxybutynin

scientific article published on 01 December 2019

Successful Treatment of Scar Pain with Scrambler Therapy

scientific article published on 14 October 2019

T cell receptor repertoire features associated with survival in immunotherapy-treated pancreatic ductal adenocarcinoma

scientific article published on 12 July 2018

Targeting neoantigens to augment antitumour immunity

scientific article published on 01 August 2017

The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma

scientific article

The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma.

scientific article published on 09 January 2018

Tumor Mutational Burden and Response Rate to PD-1 Inhibition.

scientific article published in December 2017

Weakness and Myalgia in a Patient With Hepatocellular Carcinoma Undergoing Checkpoint Inhibitor Therapy

scientific article published on 29 August 2019

pAKT Expression and Response to Sorafenib in Differentiated Thyroid Cancer.

scientific article

Paulina is supported by:

About Paulina

Help